spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Cadence Pharmaceuticals 

 HSMN NewsFeed - 4 Oct 2022
Saluda Medical Appoints Laureen DeBuono to Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 3 Apr 2018
Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Nov 2017
Outpost Medicine Appoints Scott Byrd as Chief Executive Officer and Raises $20 Million in Series A Financing Extension
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 30 Jun 2014
Cidara Therapeutics Completes $32 Million Series A Financing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2014
Mallinckrodt Pharmaceuticals’ New Drug Application Accepted for Review by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Apr 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Mar 2014
Zogenix Appoints James Breitmeyer to Its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Dec 2013
Evoke Pharma Strengthens Executive Team With Appointments of Chief Medical Officer and Senior Director of Clinical Operations
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 28 Feb 2012
Michael L. Eagle Appointed to Hansen Medical's Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 18 Jan 2011
Cadence Pharmaceuticals Announces U.S. Launch and Availability of OFIRMEV (acetaminophen) Injection
Biopharmaceuticals
 HSMN NewsFeed - 2 Nov 2010
Cadence Pharmaceuticals Announces FDA Approval of OFIRMEV (acetaminophen) injection for the Management of Pain and Fever
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Mar 2010
Cadence Pharmaceuticals Appoints Michael L. Eagle to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2010
Cadence Pharmaceuticals Receives Complete Response Letter from FDA for Intravenous Acetaminophen NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jun 2009
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2009
Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Dec 2008
Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Biopharmaceuticals
 HSMN NewsFeed - 4 Sep 2008
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
Devices Venture Capital
 HSMN NewsFeed - 31 Jul 2008
Versant Ventures Announces Closing of $500 Million Venture Fund
Venture Capital
 HSMN NewsFeed - 11 Jan 2008
Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
Biopharmaceuticals
 HSMN NewsFeed - 13 Sep 2007
Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
Biopharmacetuicals Personnel
 HSMN NewsFeed - 30 Aug 2007
Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
Biopharmaceuticals
 HSMN NewsFeed - 30 Jul 2007
Cadence Pharmaceuticals Announces Agreement With FDA on Increased Enrollment In Phase III Clinical Trial of Omigard(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jun 2007
Cadence Pharmaceuticals Names Hazel Aker, J.D. Senior Vice President, General Counsel and Catherine Hardalo, M.D. Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2006
Cadence Pharmaceuticals Initiates Pivotal Phase III Clinical Trial Evaluating Intravenous Acetaminophen for Post-Operative Acute Pain
Biopharmaceuticals Surgery
 HSMN NewsFeed - 12 Oct 2006
Favrille Appoints Former Eli Lilly Executive Michael Eagle Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Aug 2006
Zogenix, Inc. Names Founding Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 14 Aug 2006
Cadence Pharmaceuticals Appoints James B. Breitmeyer, M.D., Ph.D. as Chief Medical Officer and Names Christopher J. Twomey to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2006
Cadence Pharmaceuticals Announces Additions to Senior Management and Board of Directors
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 5 additional stories matching:
Cadence Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.